Gluconeogenesis continues in premature infants receiving total parenteral nutrition

Shaji K Chacko1, Agneta L Sunehag

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.

Insights

In preterm infants on total parenteral nutrition (TPN), gluconeogenesis is sustained and accounts for most residual glucose production, even when glucose infusion exceeds normal rates. This process is independent of glucose infusion rates or blood glucose levels.

Area of Science:

  • Neonatal physiology
  • Metabolic studies
  • Parenteral nutrition

Background:

  • Preterm infants often receive total parenteral nutrition (TPN) with high glucose loads.
  • Understanding glucose metabolism in these vulnerable infants is crucial for optimizing nutritional support.

Purpose of the Study:

  • To quantify the contribution of gluconeogenesis to overall glucose production in preterm infants receiving TPN.
  • To investigate the impact of high glucose infusion rates on gluconeogenesis.

Main Methods:

  • Stable isotope-gas chromatography-mass spectrometry techniques were employed.
  • Deuterated water and the Chacko and Landau methods were used to measure glucose appearance and gluconeogenesis rates.
  • Eight preterm infants (26.5±0.5 weeks gestation) on routine TPN were studied.

Main Results:

  • Gluconeogenesis accounted for a significant portion of residual glucose production (68-73%) in preterm infants on TPN.
  • The rate of gluconeogenesis was substantial, with values around 1.3 mg/kg per min.
  • Neither the glucose infusion rate nor blood glucose concentration affected gluconeogenesis or glycogenolysis.

Conclusions:

  • Gluconeogenesis is an active and significant pathway for glucose production in preterm infants receiving TPN, even at supra-physiological glucose infusion rates.
  • The rate of gluconeogenesis is not influenced by the amount of glucose infused or the resulting blood glucose levels in this population.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...